254 related articles for article (PubMed ID: 11543687)
1. Design and synthesis of [(2,3-dichlorophenyl)piperazin-1-yl]alkylfluorenylcarboxamides as novel ligands selective for the dopamine D3 receptor subtype.
Robarge MJ; Husbands SM; Kieltyka A; Brodbeck R; Thurkauf A; Newman AH
J Med Chem; 2001 Sep; 44(19):3175-86. PubMed ID: 11543687
[TBL] [Abstract][Full Text] [Related]
2. Novel heterocyclic trans olefin analogues of N-{4-[4-(2,3-dichlorophenyl)piperazin-1-yl]butyl}arylcarboxamides as selective probes with high affinity for the dopamine D3 receptor.
Grundt P; Carlson EE; Cao J; Bennett CJ; McElveen E; Taylor M; Luedtke RR; Newman AH
J Med Chem; 2005 Feb; 48(3):839-48. PubMed ID: 15689168
[TBL] [Abstract][Full Text] [Related]
3. N-(4-[4-(2,3-dichlorophenyl)piperazin-1-yl]butyl, butenyl and butynyl)arylcarboxamides as novel dopamine D(3) receptor antagonists.
Newman AH; Cao J; Bennett CJ; Robarge MJ; Freeman RA; Luedtke RR
Bioorg Med Chem Lett; 2003 Jul; 13(13):2179-83. PubMed ID: 12798330
[TBL] [Abstract][Full Text] [Related]
4. Heterocyclic analogues of N-(4-(4-(2,3-dichlorophenyl)piperazin-1-yl)butyl)arylcarboxamides with functionalized linking chains as novel dopamine D3 receptor ligands: potential substance abuse therapeutic agents.
Grundt P; Prevatt KM; Cao J; Taylor M; Floresca CZ; Choi JK; Jenkins BG; Luedtke RR; Newman AH
J Med Chem; 2007 Aug; 50(17):4135-46. PubMed ID: 17672446
[TBL] [Abstract][Full Text] [Related]
5. Synthesis and pharmacological evaluation of potent and highly selective D3 receptor ligands: inhibition of cocaine-seeking behavior and the role of dopamine D3/D2 receptors.
Campiani G; Butini S; Trotta F; Fattorusso C; Catalanotti B; Aiello F; Gemma S; Nacci V; Novellino E; Stark JA; Cagnotto A; Fumagalli E; Carnovali F; Cervo L; Mennini T
J Med Chem; 2003 Aug; 46(18):3822-39. PubMed ID: 12930145
[TBL] [Abstract][Full Text] [Related]
6. N-[2-[4-(4-Chlorophenyl)piperazin-1-yl]ethyl]-3-methoxybenzamide: a potent and selective dopamine D4 ligand.
Perrone R; Berardi F; Colabufo NA; Leopoldo M; Tortorella V
J Med Chem; 1998 Nov; 41(24):4903-9. PubMed ID: 9822559
[TBL] [Abstract][Full Text] [Related]
7. Synthesis and structure-activity relationships of naphthamides as dopamine D3 receptor ligands.
Huang Y; Luedtke RR; Freeman RA; Wu L; Mach RH
J Med Chem; 2001 May; 44(11):1815-26. PubMed ID: 11356115
[TBL] [Abstract][Full Text] [Related]
8. Design, synthesis, and biological evaluation of structurally constrained hybrid analogues containing ropinirole moiety as a novel class of potent and selective dopamine D3 receptor ligands.
Zhou B; Hong KH; Ji M; Cai J
Chem Biol Drug Des; 2018 Sep; 92(3):1597-1609. PubMed ID: 29710404
[TBL] [Abstract][Full Text] [Related]
9. NGB 2904 and NGB 2849: two highly selective dopamine D3 receptor antagonists.
Yuan J; Chen X; Brodbeck R; Primus R; Braun J; Wasley JW; Thurkauf A
Bioorg Med Chem Lett; 1998 Oct; 8(19):2715-8. PubMed ID: 9873609
[TBL] [Abstract][Full Text] [Related]
10. In vitro pharmacological profile of YM-43611, a novel D2-like receptor antagonist with high affinity and selectivity for dopamine D3 and D4 receptors.
Hidaka K; Tada S; Matsumoto M; Ohmori J; Tasaki Y; Nomura T; Usuda S; Yamaguchi T
Br J Pharmacol; 1996 Apr; 117(8):1625-32. PubMed ID: 8732269
[TBL] [Abstract][Full Text] [Related]
11. Structure-affinity relationship study on N-[4-(4-arylpiperazin-1-yl)butyl]arylcarboxamides as potent and selective dopamine D(3) receptor ligands.
Leopoldo M; Berardi F; Colabufo NA; De Giorgio P; Lacivita E; Perrone R; Tortorella V
J Med Chem; 2002 Dec; 45(26):5727-35. PubMed ID: 12477356
[TBL] [Abstract][Full Text] [Related]
12. Phenylpiperazinylmethylheterocycle derivatives: synthesis and dopamine receptor binding profiles.
Abadi AH
Arch Pharm (Weinheim); 2004 Jul; 337(7):383-90. PubMed ID: 15237388
[TBL] [Abstract][Full Text] [Related]
13. Effects of two novel D3-selective compounds, NGB 2904 [N-(4-(4-(2,3-dichlorophenyl)piperazin-1-yl)butyl)-9H-fluorene-2-carboxamide] and CJB 090 [N-(4-(4-(2,3-dichlorophenyl)piperazin-1-yl)butyl)-4-(pyridin-2-yl)benzamide], on the reinforcing and discriminative stimulus effects of cocaine in rhesus monkeys.
Martelle JL; Claytor R; Ross JT; Reboussin BA; Newman AH; Nader MA
J Pharmacol Exp Ther; 2007 May; 321(2):573-82. PubMed ID: 17272677
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of N-phenyl homopiperazine analogs as potential dopamine D3 receptor selective ligands.
Li A; Mishra Y; Malik M; Wang Q; Li S; Taylor M; Reichert DE; Luedtke RR; Mach RH
Bioorg Med Chem; 2013 Jun; 21(11):2988-98. PubMed ID: 23618707
[TBL] [Abstract][Full Text] [Related]
15. Analogues of Arylamide Phenylpiperazine Ligands To Investigate the Factors Influencing D3 Dopamine Receptor Bitropic Binding and Receptor Subtype Selectivity.
Hayatshahi HS; Xu K; Griffin SA; Taylor M; Mach RH; Liu J; Luedtke RR
ACS Chem Neurosci; 2018 Dec; 9(12):2972-2983. PubMed ID: 30010318
[TBL] [Abstract][Full Text] [Related]
16. N-(4-(4-(2,3-dichloro- or 2-methoxyphenyl)piperazin-1-yl)butyl)heterobiarylcarboxamides with functionalized linking chains as high affinity and enantioselective D3 receptor antagonists.
Newman AH; Grundt P; Cyriac G; Deschamps JR; Taylor M; Kumar R; Ho D; Luedtke RR
J Med Chem; 2009 Apr; 52(8):2559-70. PubMed ID: 19331412
[TBL] [Abstract][Full Text] [Related]
17. Development of novel 1,2,3,4-tetrahydroisoquinoline derivatives and closely related compounds as potent and selective dopamine D3 receptor ligands.
Mach UR; Hackling AE; Perachon S; Ferry S; Wermuth CG; Schwartz JC; Sokoloff P; Stark H
Chembiochem; 2004 Apr; 5(4):508-18. PubMed ID: 15185375
[TBL] [Abstract][Full Text] [Related]
18. First structure-activity relationship study on dopamine D3 receptor agents with N-[4-(4-arylpiperazin-1-yl)butyl]arylcarboxamide structure.
Leopoldo M; Lacivita E; Colabufo NA; Contino M; Berardi F; Perrone R
J Med Chem; 2005 Dec; 48(25):7919-22. PubMed ID: 16335915
[TBL] [Abstract][Full Text] [Related]
19. Dopamine D2, D3, and D4 selective phenylpiperazines as molecular probes to explore the origins of subtype specific receptor binding.
Ehrlich K; Götz A; Bollinger S; Tschammer N; Bettinetti L; Härterich S; Hübner H; Lanig H; Gmeiner P
J Med Chem; 2009 Aug; 52(15):4923-35. PubMed ID: 19606869
[TBL] [Abstract][Full Text] [Related]
20. Structure-selectivity investigations of D2-like receptor ligands by CoMFA and CoMSIA guiding the discovery of D3 selective PET radioligands.
Salama I; Hocke C; Utz W; Prante O; Boeckler F; Hübner H; Kuwert T; Gmeiner P
J Med Chem; 2007 Feb; 50(3):489-500. PubMed ID: 17266201
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
